Related Experiment Video
Updated: Jun 21, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Pathogenesis of neurologic manifestations of Mycoplasma pneumoniae infection
1Department of Pediatrics, Sapporo Tetsudo Hospital, N 3 E 1 Chuo-ku, Sapporo 060-0033, Japan. naritamy@d5.dion.ne.jp
Abstract:
Mycoplasma pneumoniae has been associated with various neurologic manifestations, but exactly how the organism can cause such a wide variety of diseases is a long-standing mystery. In this respect, although pneumonia has been considered the hallmark of Mycoplasma pneumoniae infection, emerging accumulations of data have revealed that the infection can cause a number of extrapulmonary manifestations even in the absence of pneumonia. The importance of host immune response in the pathomechanism of pneumonia has been established, but the pathomechanisms of extrapulmonary manifestations remain largely unknown. For this review, extrapulmonary manifestations due to M. pneumoniae infection were classified into three categories: a direct type, in which locally induced cytokines must play a role; an indirect type, in which immune modulation such as autoimmunity must play a role; and a vascular occlusion type, in which vasculitis or thrombosis (either or both, and with or without systemic hypercoagulable state) must play a role. This classification was then applied within a literature review for neurologic manifestations. Most neurologic manifestations due to M. pneumoniae infection could be reasonably classified into and explained by one of the three types of pathomechanisms.
Insights
Mycoplasma pneumoniae infections can cause various neurologic issues beyond pneumonia. This review classifies these extrapulmonary effects into direct, indirect, and vascular occlusion types, explaining their mechanisms.
Area of Science:
- Neurology
- Infectious Diseases
- Immunology
Background:
- Mycoplasma pneumoniae is linked to diverse neurologic conditions.
- Extrapulmonary manifestations occur even without pneumonia.
- Pathomechanisms for extrapulmonary effects are poorly understood.
Purpose of the Study:
- To review and classify extrapulmonary manifestations of Mycoplasma pneumoniae infection.
- To elucidate the pathomechanisms underlying these manifestations, particularly neurologic ones.
Main Methods:
- Literature review of Mycoplasma pneumoniae-associated extrapulmonary diseases.
- Classification of pathomechanisms into direct, indirect (autoimmune), and vascular occlusion types.
- Application of this classification to neurologic manifestations.
Main Results:
- Most Mycoplasma pneumoniae-related neurologic manifestations fit into the proposed three pathomechanism categories.
- Direct type involves local cytokine induction.
- Indirect type involves immune modulation and autoimmunity.
- Vascular occlusion type involves vasculitis or thrombosis.
Conclusions:
- A three-tiered classification system effectively explains Mycoplasma pneumoniae-induced neurologic manifestations.
- Understanding these mechanisms aids in diagnosing and managing these diverse conditions.
Related Concept Videos
Atypical Pneumonia
Bacterial Meningitis II: Pathophysiology
Bacterial Meningitis I: Introduction
Bacterial Meningitis
Cryptococcal Meningitis
Encephalitis ll: Pathophysiology